Growth Metrics

Aptargroup (ATR) EBITDA Margin (2009 - 2026)

Aptargroup (ATR) reported EBITDA Margin of 17.48% for Q1 2026, down 149.0% year-over-year from 35.67% in Q1 2025, and down 1.69% on a QoQ basis from 17.78% in Q4 2025.

Aptargroup (ATR) has 18 years of EBITDA Margin data on file, last reported at 17.48% in Q1 2026.

  • Quarterly EBITDA Margin fell 149.0% year-over-year to 17.48% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.28% (down 95.0% YoY) and the FY2025 annual result came in at 19.68%, down 31.0% from the prior year.
  • EBITDA Margin fell to 17.48% in Q1 2026 per ATR's latest filing, from 17.78% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 21.29% in Q3 2024 and bottomed at 15.38% in Q1 2023.
  • The 5-year median for EBITDA Margin is 18.04% (2024), against an average of 18.49%.
  • The widest annual swing landed in 2024, when EBITDA Margin jumped 447 bps; it then plunged 307 bps in 2025.
  • Tracing ATR's EBITDA Margin over 5 years: stood at 16.75% in 2022, then decreased by 2 bps to 16.38% in 2023, then grew by 27 bps to 20.85% in 2024, then fell by 15 bps to 17.78% in 2025, then fell by 2 bps to 17.48% in 2026.
  • Per Business Quant, the three latest ATR EBITDA Margin figures stand at 17.48% (Q1 2026), 17.78% (Q4 2025), and 20.87% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 28.86%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 1.97%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 34.92%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 20.96%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 4.04%
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 19.85%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 13.65%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.44%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 17.48%
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn -1.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17.48%
Dec 31, 2025 17.78%
Sep 30, 2025 20.87%
Jun 30, 2025 21.04%
Mar 31, 2025 18.97%
Dec 31, 2024 20.85%
Sep 30, 2024 21.29%
Jun 30, 2024 19.85%
Mar 31, 2024 18.04%
Dec 31, 2023 16.38%
Sep 30, 2023 19.11%
Jun 30, 2023 18.72%
Mar 31, 2023 15.38%
Dec 31, 2022 16.75%
Sep 30, 2022 16.98%
Jun 30, 2022 17.60%
Mar 31, 2022 17.20%
Dec 31, 2021 16.78%
Sep 30, 2021 15.99%
Jun 30, 2021 16.32%
Mar 31, 2021 18.05%
Dec 31, 2020 17.30%
Sep 30, 2020 19.04%
Jun 30, 2020 16.39%
Mar 31, 2020 18.19%
Dec 31, 2019 17.38%
Sep 30, 2019 12.87%
Jun 30, 2019 14.79%
Mar 31, 2019 13.04%
Dec 31, 2018 8.21%
Sep 30, 2018 9.18%
Jun 30, 2018 11.39%
Mar 31, 2018 12.51%
Dec 31, 2017 12.65%
Sep 30, 2017 12.96%
Jun 30, 2017 13.82%
Mar 31, 2017 12.97%
Dec 31, 2016 12.71%
Sep 30, 2016 13.96%
Jun 30, 2016 15.10%
Mar 31, 2016 11.89%
Dec 31, 2015 12.25%
Sep 30, 2015 15.02%
Jun 30, 2015 16.07%
Mar 31, 2015 12.42%
Dec 31, 2014 -23.66%
Sep 30, 2014 12.06%
Jun 30, 2014 12.51%
Mar 31, 2014 11.47%
Dec 31, 2013 -19.54%
Sep 30, 2013 11.76%
Jun 30, 2013 12.61%
Mar 31, 2013 10.46%
Dec 31, 2012 9.55%
Sep 30, 2012 11.34%
Jun 30, 2012 11.37%
Mar 31, 2012 11.90%
Dec 31, 2011 -23.50%
Sep 30, 2011 12.34%
Jun 30, 2011 13.05%
Mar 31, 2011 12.10%
Dec 31, 2010 -22.18%
Sep 30, 2010 13.69%
Jun 30, 2010 13.94%
Mar 31, 2010 12.19%
Dec 31, 2009 11.48%
Sep 30, 2009 11.18%
Jun 30, 2009 10.89%